Bimi International Medical Inc (BIMI) - Total Liabilities
Based on the latest financial reports, Bimi International Medical Inc (BIMI) has total liabilities worth $24.90 Million USD as of September 2023. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Bimi International Medical Inc - Total Liabilities Trend (2002–2022)
This chart illustrates how Bimi International Medical Inc's total liabilities have evolved over time, based on quarterly financial data. See BIMI current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Bimi International Medical Inc Competitors by Total Liabilities
The table below lists competitors of Bimi International Medical Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ordinary Fully Paid Deferred Settlement
AU:EPXDA
|
Australia | AU$12.32 Million |
|
Fox Marble Holdings PLC
LSE:FOX
|
UK | GBX437.10K |
|
Bangkok Expressway and Metro PCL F
F:B4X
|
Germany | €114.55 Billion |
|
BANPU PCL -FGN- BA 1
F:BPFG
|
Germany | €9.05 Billion |
|
Sonder Holdings Inc. Class A
NASDAQ:SONDQ
|
USA | $1.49 Billion |
|
Mazhar Zorlu Holding AS
IS:MZHLD
|
Turkey | TL100.41 Million |
Liability Composition Analysis (2002–2022)
This chart breaks down Bimi International Medical Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Bimi International Medical Inc market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.21 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.86 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.71 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bimi International Medical Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bimi International Medical Inc (2002–2022)
The table below shows the annual total liabilities of Bimi International Medical Inc from 2002 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-12-31 | $30.50 Million | +13.83% |
| 2021-12-31 | $26.79 Million | +64.28% |
| 2020-12-31 | $16.31 Million | -24.32% |
| 2019-12-31 | $21.55 Million | +64.93% |
| 2018-12-31 | $13.07 Million | -7.58% |
| 2017-12-31 | $14.14 Million | +33.21% |
| 2016-12-31 | $10.61 Million | -24.07% |
| 2015-12-31 | $13.98 Million | -17.65% |
| 2014-12-31 | $16.97 Million | +56.98% |
| 2013-12-31 | $10.81 Million | -16.95% |
| 2012-12-31 | $13.02 Million | -8.96% |
| 2011-12-31 | $14.30 Million | +83.85% |
| 2010-12-31 | $7.78 Million | +42.65% |
| 2009-12-31 | $5.45 Million | +117.70% |
| 2008-12-31 | $2.50 Million | +46.65% |
| 2007-12-31 | $1.71 Million | +36.43% |
| 2006-12-31 | $1.25 Million | +95.54% |
| 2005-12-31 | $640.17K | +18.04% |
| 2004-12-31 | $542.33K | +71.98% |
| 2003-12-31 | $315.35K | +74.20% |
| 2002-12-31 | $181.03K | -- |
About Bimi International Medical Inc
BIMI Holdings Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical solution, and pharmaceutical and other healthcare products in the People's Republic of China and the United States. The company operates through four segments: Medical Devices; Healthcare Products; Wholesale Pharmaceuticals; and Pharmacy Retail. The Pharmacy Retail segment offers prescr… Read more